Product
LMN-101
1 clinical trial
1 indication
Indication
Campylobacter InfectionsClinical trial
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Single Dose Regimen Study of LMN-101 in Healthy Volunteers Challenged With Campylobacter JejuniStatus: Completed, Estimated PCD: 2022-10-04